Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Clinical trial NCT02725593 · COMPLETED
Trial details
- NCT number
- NCT02725593
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-22
- Primary completion
- 2020-04-06
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.